PCYT2 and fatty liver disease: Thiamine mitigated visceral adipocyte hypertrophy, liver steatosis, and skeletal muscle insulin resistance without causing damage to heart or kidneys and microarray data show that Pcyt2 was up-regulated in liver of the rats who received thiamine treatment [58].